InformationPIK-III (VPS34-IN2), which is a selective inhibitor of VPS34 enzymatic activity, inhibitsautophagyand de novo lipidation of LC3 and leads to the stabilization of autophagy substrates. The IC50 values for VPS34 and PI(3)Kδ are 0.018 μM and 1.2 μM respectively.TargetsVps34 (Cell-free assay); PI3Kδ (Cell-free assay) 0.018μM; 1.2μMIn vitroVPS34 enzymatic function is essential for LC3 lipidation in mammalian cells and PIK-III is a robust inhibitor of autophagy and LC3 lipidation in mammalian cells.In H4 cells, PIK-III inhibits the formation of autolysosomes and increases the cytosolic signal of LC3 under basal conditions and when autophagy is induced with the mTOR inhibitor AZD8055.In a CCCP-induced mitophagy model, PIK-III inhibits the clearance of mitochondria.PIK-III treatment leads to an increase in the levels of LC3-I in H4 and PSN1 cells.In Panc10.05 cells, PIK-III increases the levels of LC3-II in parallel with LC3-I suggesting a cell type-specific response.Cell Research(from reference)Cell lines:H4 cells/ HeLa cells Concentrations:2.5μM in H4 cells/5μM in Hela cells Incubation Time:overnight for H4 cells/12h for Hela cells.
Specifications and Purity: ≥99%
Molecular Formula: C17H17N7
Molecular Weight: 319.36
PubChem CID: 67983123
Isomeric SMILES: C1CC1CC2=NC(=NC=C2C3=NC(=NC=C3)NC4=CC=NC=C4)N
- UPC:
- 42295205
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P413812-25mg
- CAS:
- 1383716-40-2
- Product Size:
- 25mg
akash.verma@cenmed.com
(732) 447-1115





